This is the authors' abstract. We don't add key points for this paper.
Integrating multiple components to realize cancer diagnosis and therapy in a single theranostic nanoplatform has drawn considerable attention. Herein, a multifunctional theranostic nanoplatform (mSiO 2 @PbS/CdS-Fe 3 O 4 ) was successfully fabricated by carefully designing thiol-modified large-pore mesoporous silica nanospheres (mSiO 2 ), followed by coordination-driven embedding of Fe 3 O 4 nanoparticles (NPs) and PbS/CdS quantum dots (QDs) inside. The excellent feature of near-infrared (NIR) excitation and NIR emission of PbS/CdS QDs enables deep-tissue photoluminescence imaging, which was demonstrated ex vivo with tissue as thick as 14 mm. Meanwhile, owing to the presence of superparamagnetic Fe 3 O 4 NPs, mSiO 2 @PbS/CdS-Fe 3 O 4 can be rapidly confined under an external magnetic field (MF), and exhibit a significantly high T 2 relaxivity in T 2 -weighted magnetic resonance (MR) images in vivo. When mSiO 2 @PbS/CdS-Fe 3 O 4 was exposed to external physical stimuli of MF and/or NIR laser, they produced strong local heating through magnetothermal/photothermal effects. Owing to the unique mesoporous structure of mSiO 2 @PbS/CdS-Fe 3 O 4, doxorubicin (DOX) was readily loaded into them and the drug-release profile was subsequently evaluated under multistimuli (pH/MF/NIR). The release of DOX was significantly enhanced at lower pH, and higher temperatures caused by magnetothermal/photothermal effects. Our results pave the road toward developing a highly powerful nanoplatform for bimodal imaging (NIR deep-tissue photoluminescence and MR imaging), and simultaneously for integrating synergistic treatment capabilities of hyperthermia and pH/MF/NIR-responsive drug release.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: